What is Innoblative Designs?
Innoblative Designs operates as a specialized medical device manufacturer dedicated to refining surgical outcomes for patients diagnosed with breast cancer and various soft tissue pathologies. The company's flagship innovation, the SIRA RFA Electrosurgical Device, has secured Breakthrough Device Designation from the FDA, marking a significant regulatory achievement. This technology is engineered for precise intraoperative coagulation and ablation, specifically targeting the critical need for improved margin control during breast-conserving procedures. By addressing the high incidence of reoperation, Innoblative Designs is effectively positioning itself as a pivotal player in the surgical oncology market, focusing on high-precision tools that mitigate clinical risks and enhance patient recovery profiles.
How much funding has Innoblative Designs raised?
Innoblative Designs has raised a total of $4.4M across 3 funding rounds:
Debt
$1.2M
Private Equity
$1M
Private Equity
$2.3M
Debt (2014): $1.2M, investors not publicly disclosed
Private Equity (2016): $1M, investors not publicly disclosed
Private Equity (2017): $2.3M, investors not publicly disclosed
Key Investors in Innoblative Designs
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Innoblative Designs?
With the support of its recent capital injection, Innoblative Designs is poised to accelerate the clinical validation and market entry of its platform technologies. The strategic focus remains on scaling the deployment of the SIRA system while simultaneously expanding its portfolio to address broader unmet needs in soft tissue surgery. As the company transitions into a more mature operational phase, stakeholders are looking toward expanded clinical trials and potential partnerships that could integrate their electrosurgical solutions into standard hospital workflows. The emphasis on reducing reoperation rates provides a compelling value proposition for healthcare providers, setting the stage for sustained growth in the competitive medical device landscape.
See full Innoblative Designs company page
